Click the star to add/remove an item to/from your individual schedule.
You need to be logged in to avail of this functionality.

Accepted Paper

Mending and bending antimalarial drug innovation at times of emerging multi-drug resistance in Southeast Asia  
Birgit Ruth Buergi (Independent)

Send message to Author

Paper short abstract

See below.

Paper long abstract

First signs of artemisinin resistance in P. falciparum malaria along the Cambodia-Thailand border threaten the vision of a malaria-free world. The international malaria community has therefore renewed calls for sustained financial investment in malaria eradication to avert a potential global health disaster. The controversially discussed question of what the world would be with, or without, the introduction of a co-buyer based drug subsidy for antimalarials, brings into perspective its underlying symbolic logic embossed in the logo to be printed on the packaging of artemisinin-based combination therapies that will be channelled through the Affordable Medicines Facility - malaria. Genealogies of health crises have their own theoretical appeal. My ethnographic analysis however, has a different take on the world's cradle of antimalarial drug resistance.

Panel W091
Medicating crisis
  Session 1